bladder trabeculation
significant PVR
low peak flow rate
high IPSS
A. bladder trabeculation
PVP
HoLEP
HoLRP
TUMT
enoxaparin
silodosin
finasteride
tolterodine
2 weeks after performing prostatic urethral lift
6-month treatment with 5α-reductase inhibitors
after placing a stent in the prostatic urethra
immediately after removing one-half of the prostate by TURP
alfuzosin
silodosin
finasteride
tamsulosin
symptoms begin with a serum sodium of less than 120 mEq/L
the mortality is 2.7-5.8 %
manifestations rely on acute changes in the intravascular volume and plasma solute concentrations
the preferred height of irrigating fluid is 60 cm above the patient
TUIP
TURP
HoLEP
HoLRP
it focuses on last month`s symptoms
scores of moderate symptoms suggest surgical treatment if the patient`s quality of life was poor
it has been validated and translated to many languages
all of the above
532 nm
694 nm
755 nm
1064 nm
bladder stones
BPH
prostatitis syndrome
. What is (are) the indication(s) of antimuscarinic agents and PDEIs
the presence of prostate cancer
previous prostatectomy
all of the above
. Robot-assisted laparoscopic prostatectomy for prostatic adenoma has the following advantage over TURP:
the size of the prostate correlates well to the degree of obstruction
a decrease of 3 points in IPSS is associated with a subjective perception of improvement
median lobe enlargement gives rise to serious obstructive symptoms
bladder trabeculation is not specific for an obstructing prostate
intra-prostatic levels of estrogen decrease in men with BPH
stimulation of the adrenergic nervous system results in a dynamic increase in prostatic urethral resistance
inflammation may play a role through cytokines to promote cell growth
hyperplasia occurs due to an imbalance between cell death and cell proliferation
urolithiasis
receiving chemotherapy
upper tract surgery
painless hematuria
calcium channel blockers
antihistamines
antidepressants
cold medications containing pseudoephedrine
LUTS with neurologic disease
LUTS with post-void dribble
LUTS with suspicious DRE
LUTS with hematuria
an additional 15 g in prostate weight
each centimeter over the normal 1.5-cm prostate urethral length equates
an additional 5 g in prostate weight
. When comparing suprapubic to retropubic prostatectomy for removing prostatic adenoma, the former allows:
small prostate
mainly median lobe hypertrophy
history of urinary retention
mainly irritative symptoms
each centimeter over the normal 2-cm prostate urethral length equates
an additional 12 g in prostate weight
each centimeter over the normal 2.5-cm prostate urethral length equates
an additional 10 g in prostate weight
BPH is an inheritable and progressive disease
familial BPH presents at an older age when compared to sporadic cases
approximately 90% of men in their 80s have histologic evidence of BPH
BPH tends to be more severe and progressive in black men when compared to whites
the neurological status of the patient
PVR
severity of obstructive LUTS
all of the above
never
unlikely
likely
always
smaller incisions with a shorter hospital stay
lower risk for blood transfusion
none of the above
. What is the first-line management of uncomplicated LUTS due to large prostate?
IPSS
post void residual
prostate volume
Q-max at uroflowmetry
is specific for prostate symptom
is a seven-question, self-administered questionnaire that yields a total score that ranges from 0 to 35
a sum of 20 on IPSS scale is severe
it covers both voiding and storage symptomatology
milder postoperative hematuria
tension-free bladder closure
extra-peritoneal approach
. When comparing TURP to open prostatectomy for removing prostatic adenoma, the latter has the following advantages, EXCEPT:
hematuria and infections
migration and encrustation of the stent
irritative urinary symptoms and painful ejaculation
all of the above
IPSS cannot be used to establish the diagnosis of BPH/LUTS
prostate biopsy is essential in diagnosing BPH and excluding cancers
PSA and uroflowmetry help diagnose the condition
none of the above
before catheterization
after catheterization and before TURP
immediately after TURP
2 weeks after TURP
cetrorelix
flutamide
dutasteride
zanoterone
bladder stones
prostate cancer
renal insufficiency
bladder diverticula